Moody’s assigns ‘A2’ rating to Palomar Health’s GO refunding bonds

Moody’s Investors Service has assigned an “A2” rating to Escondido, Calif.-based Palomar Health’s series 2016A and 2016B general obligation refunding bonds expected to be issued for $50 million and $160 million, respectively.

Advertisement

The “A2” rating assignment is based on several factors, including Palomar Health’s ongoing growth in assessed valuation and improved financial operations.

The outlook is stable, reflecting Palomar Health’s improved operating performance and liquidity levels.

More articles on healthcare finance:
Chinese billionaire ups stake in CHS for $31.9M
Fazzi to create 300 jobs in Ireland with new healthcare services and coding company
Health management company launches RCM subsidiary

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.